Contraceptives Global Market Report 2025

Description

Contraceptive refers to a method or act that involves the use of a variety of medicines, sexual behaviours, chemicals, medications, or surgical procedures to intentionally prevent conception. Contraceptive is any method, measure, or action designed to keep a woman from getting pregnant.

The main product types of contraceptives include oral contraceptive pills, topical contraceptives, injectables, diaphragms, vaginal rings, condoms, contraceptive sponges, subdermal implants, and intra-uterine devices. Oral contraceptive pills are contraceptive tablets or birth control pills to prevent pregnancy. It includes hormones that prevent eggs from being released from the ovaries. The contraceptives are used by a wide range of age groups, ranging from 15-24 years, 25-34 years, 35-44 years, and over 44 years. The contraceptives are distributed by clinics, hospitals, independent pharmacies, and other locations.

The contraceptives market research report is one of a series of new reports from The Business Research Company that provides contraceptives market statistics, including contraceptives industry global market size, regional shares, competitors with a contraceptives market share, detailed contraceptives market segments, market trends and opportunities, and any further data you may need to thrive in the contraceptives industry. This contraceptives market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The contraceptives market size has grown strongly in recent years. It will grow from $27.92 billion in 2024 to $30.05 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to introduction of The birth control pill, increased awareness and education about contraception, legal and social changes promoting reproductive rights, global population control initiatives, increase inThe use of generic and low-cost drugs and devices.

The contraceptives market size is expected to see strong growth in the next few years. It will grow to $40.89 billion in 2029 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to growing focus on male contraceptives, increased access to contraception in developing countries, integration of digital health technologies in contraception, rising demand for long-acting reversible contraceptives (LARCS), growing accessibility to over-the-counter drugs on the online platform. Major trends in the forecast period include technological advancements in contraceptive methods, shift towards non-hormonal and natural contraceptive methods, expansion of over-the-counter access to certain contraceptives, emphasis on user-friendly and discreet contraceptive options, integration of telemedicine in contraceptive counseling and prescriptions.

The rising frequency of sexually transmitted illnesses or diseases is driving the demand for contraceptives. Sexually transmitted diseases (STDs) are infections spread from one person to another through sexual interaction. The most typical contact occurs during anal, oral, and vaginal intercourse and they can spread through other close physical contact methods. Contraceptives are employed to manage the transmission of sexually transmitted diseases like herpes and HPV, primarily through skin-to-skin contact. For instance, in May 2023, according to the Minnesota Department of Health, a US-based state health agency of the State of Minnesota, primary and secondary syphilis cases climbed 19% in 2022, from 564 in 2021 to 676 in 2022. In 2022, 20 instances of congenital syphilis in babies were recorded. This represents a 42 % rise from 2021 when 14 cases of congenital syphilis were documented. Therefore, the increase in sexually transmitted illnesses or diseases is expected to boost the demand for contraceptives during the forecast period.

The global rise in population rates is expected to propel the growth of the contraceptive market in the coming years. Population refers to the overall number of individuals, species, or people living in a certain geographic region, country, or the entire planet. Contraceptives play a significant part in decreasing population by allowing couples and individuals to regulate and plan their household size and child spacing. For instance, in December 2022, according to the United Nations Conference on Trade and Development, a Switzerland-based intergovernmental body inside the United Nations Secretariat that promotes developing nations' interests in global commerce, the global population is expected to have increased by 0. 9% in 2021 and to exceed 8 billion by 2022. Therefore, the global rise in population rates is driving the contraceptive market.

Major companies in the contraceptives market are concentrating on developing innovative products such as Single Rod Subdermal Implants and Subcutaneous Injectable Contraceptives to improve user convenience, boost effectiveness, and provide long-term birth control solutions. These advancements aim to minimize the need for frequent dosing, enhance accessibility, and reduce side effects, offering more reliable and discreet contraceptive options for individuals seeking improved reproductive health management. For example, in October 2023, India's Health and Family Welfare Ministry introduced two new methods-the Single Rod Subdermal Implant and Subcutaneous Injectable Contraceptive-under the National Family Planning Programme to enhance family planning services. These methods are designed to improve maternal and infant health outcomes by offering more family planning options. The introduction of these contraceptives aims to lower maternal and infant morbidity and mortality rates. This initiative is part of a larger effort to improve reproductive health services in Karnataka, ensuring that women have access to safe and effective contraceptive methods.

Major companies operating in the contraceptives market are focusing on innovative products, such as Opill, progestin-only daily oral contraceptives, to better meet the needs of their existing consumers. Opill progestin-only daily oral contraceptives, often known as the mini-pill, are a kind of birth control pill that includes just progestin, a synthetic version of the hormone progesterone. For instance, in July 2023, Perrigo Company plc, an Ireland-based manufacturing company of over-the-counter pharmaceuticals, announced U. S. Food and Drug Administration (FDA) approval for Opill progestin-only daily oral contraceptives. Opill is the very first birth control pill available without a prescription in the United States. Opill can significantly improve women's availability of contraceptives and is a genuine testament to Perrigo's constant dedication to delivering meaningful solutions that improve people's lives.

In March 2024, Insud Pharma, a Spain-based pharmaceutical manufacturer, acquired oral and injectable contraceptives from Viatris for an undisclosed amount. This acquisition allows Insud Pharma to strengthen its women's health product portfolio by incorporating Viatris' contraceptive offerings, expanding its market presence, and providing a wider range of reproductive healthcare solutions to meet the increasing demand for contraceptive options. Viatris, a US-based pharmaceutical company, specializes in the manufacturing of pharmaceuticals.

Major companies operating in the contraceptives market include Merck & Co. Inc., Bayer AG, Church & Dwight Co. Inc., Cipla Inc., Reckitt Benckiser Group plc, Agile Therapeutics Inc., Allergan Ltd., Aurobindo Pharma Limited, Famy Care Ltd., Glenmark Pharmaceuticals Limited, HLL Lifecare Limited, Johnson & Johnson, Laboratoire HRA Pharma SAS, Lupin Limited, Mankind Pharma Ltd., Mayer Laboratories Inc., Medisafe Distribution Inc., Mithra Pharmaceuticals SA, Mylan NV, Okamoto Industries Inc., Pfizer Inc., Pregna International Ltd., Syncom Pharmaceuticals, Teva Pharmaceutical Industries Ltd., The Population Council, Veru Inc., Zydus Cadila, Shanghai Dahua Pharmaceutical Co. Ltd., Sichuan Kangdi Pharmaceutical Co. Ltd., Beijing Zhengyuan Pharmaceutical Co. Ltd., Zhejiang Huahai Pharmaceutical Co. Ltd., Chongqing Pharmaceutical Group Co. Ltd.

North America was the largest region in the contraceptives market in 2024 and is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the contraceptives market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The contraceptive market consists of sales of combined pills, Contraceptive patch, and female condoms. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Contraceptives Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on contraceptives market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for contraceptives ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The contraceptives market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product: Oral Contraceptive Pills; Topical Contraceptives; Injectables; Diaphragms; Vaginal Rings; Condoms; Contraceptive Sponges; Subdermal Implants; Intra-Uterine Devices
2) By Age Group: 15-24 Years; 25-34 Years; 35-44 Years; 44 Years
3) By Distribution Channel: Hospital Pharmacies; Independent Pharmacies; Online Pharmacies; Clinics; Other Distribution Channels
Subsegments:
1) By Oral Contraceptive Pills: Combination Pills; Progestin-Only Pills
2) By Topical Contraceptives: Transdermal Patches; Gel Applications
3) By Injectables: Hormonal Injectables; Non-Hormonal Injectables
4) By Diaphragms: Silicone Diaphragms; Latex Diaphragms
5) By Vaginal Rings: Hormonal Rings; Non-Hormonal Rings
6) By Condoms: Male Condoms; Female Condoms
7) By Contraceptive Sponges: Non-Hormonal Sponges; Hormonal Sponges
8) By Subdermal Implants: Hormonal Implants; Non-Hormonal Implants
9) By Intra-Uterine Devices (IUDs): Hormonal IUDs; Copper IUDs
Companies Mentioned: Merck & Co. Inc.; Bayer AG; Church & Dwight Co. Inc.; Cipla Inc.; Reckitt Benckiser Group plc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r21304

1. Executive Summary

2. Contraceptives Market Characteristics

3. Contraceptives Market Trends And Strategies

4. Contraceptives Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Contraceptives Growth Analysis And Strategic Analysis Framework

5.1. Global Contraceptives PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Contraceptives Market Growth Rate Analysis
5.4. Global Contraceptives Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Contraceptives Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Contraceptives Total Addressable Market (TAM)

6. Contraceptives Market Segmentation

6.1. Global Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Contraceptive Pills
Topical Contraceptives
Injectables
Diaphragms
Vaginal Rings
Condoms
Contraceptive Sponges
Subdermal Implants
Intra-Uterine Devices
6.2. Global Contraceptives Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15-24 Years
25-34 Years
35-44 Years

44 Years

6.3. Global Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Independent Pharmacies
Online Pharmacies
Clinics
Other Distribution Channels
6.4. Global Contraceptives Market, Sub-Segmentation Of Oral Contraceptive Pills, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Combination Pills
Progestin-Only Pills
6.5. Global Contraceptives Market, Sub-Segmentation Of Topical Contraceptives, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Transdermal Patches
Gel Applications
6.6. Global Contraceptives Market, Sub-Segmentation Of Injectables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hormonal Injectables
Non-Hormonal Injectables
6.7. Global Contraceptives Market, Sub-Segmentation Of Diaphragms, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Silicone Diaphragms
Latex Diaphragms
6.8. Global Contraceptives Market, Sub-Segmentation Of Vaginal Rings, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hormonal Rings
Non-Hormonal Rings
6.9. Global Contraceptives Market, Sub-Segmentation Of Condoms, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Male Condoms
Female Condoms
6.10. Global Contraceptives Market, Sub-Segmentation Of Contraceptive Sponges, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Non-Hormonal Sponges
Hormonal Sponges
6.11. Global Contraceptives Market, Sub-Segmentation Of Subdermal Implants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hormonal Implants
Non-Hormonal Implants
6.12. Global Contraceptives Market, Sub-Segmentation Of Intra-Uterine Devices (IUDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hormonal IUDs
Copper IUDs

7. Contraceptives Market Regional And Country Analysis

7.1. Global Contraceptives Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Contraceptives Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Contraceptives Market

8.1. Asia-Pacific Contraceptives Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Contraceptives Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Contraceptives Market

9.1. China Contraceptives Market Overview
9.2. China Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Contraceptives Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Contraceptives Market

10.1. India Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Contraceptives Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Contraceptives Market

11.1. Japan Contraceptives Market Overview
11.2. Japan Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Contraceptives Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Contraceptives Market

12.1. Australia Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Contraceptives Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Contraceptives Market

13.1. Indonesia Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Contraceptives Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Contraceptives Market

14.1. South Korea Contraceptives Market Overview
14.2. South Korea Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Contraceptives Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Contraceptives Market

15.1. Western Europe Contraceptives Market Overview
15.2. Western Europe Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Contraceptives Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Contraceptives Market

16.1. UK Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Contraceptives Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Contraceptives Market

17.1. Germany Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Contraceptives Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Contraceptives Market

18.1. France Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Contraceptives Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Contraceptives Market

19.1. Italy Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Contraceptives Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Contraceptives Market

20.1. Spain Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Contraceptives Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Contraceptives Market

21.1. Eastern Europe Contraceptives Market Overview
21.2. Eastern Europe Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Contraceptives Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Contraceptives Market

22.1. Russia Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Contraceptives Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Contraceptives Market

23.1. North America Contraceptives Market Overview
23.2. North America Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Contraceptives Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Contraceptives Market

24.1. USA Contraceptives Market Overview
24.2. USA Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Contraceptives Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Contraceptives Market

25.1. Canada Contraceptives Market Overview
25.2. Canada Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Contraceptives Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Contraceptives Market

26.1. South America Contraceptives Market Overview
26.2. South America Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Contraceptives Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Contraceptives Market

27.1. Brazil Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Contraceptives Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Contraceptives Market

28.1. Middle East Contraceptives Market Overview
28.2. Middle East Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Contraceptives Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Contraceptives Market

29.1. Africa Contraceptives Market Overview
29.2. Africa Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Contraceptives Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Contraceptives Market Competitive Landscape And Company Profiles

30.1. Contraceptives Market Competitive Landscape
30.2. Contraceptives Market Company Profiles
- 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Church & Dwight Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Cipla Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Reckitt Benckiser Group plc Overview, Products and Services, Strategy and Financial Analysis

31. Contraceptives Market Other Major And Innovative Companies

31.1. Agile Therapeutics Inc.
31.2. Allergan Ltd.
31.3. Aurobindo Pharma Limited
31.4. Famy Care Ltd.
31.5. Glenmark Pharmaceuticals Limited
31.6. HLL Lifecare Limited
31.7. Johnson & Johnson
31.8. Laboratoire HRA Pharma SAS
31.9. Lupin Limited
31.10. Mankind Pharma Ltd.
31.11. Mayer Laboratories Inc.
31.12. Medisafe Distribution Inc.
31.13. Mithra Pharmaceuticals SA
31.14. Mylan NV
31.15. Okamoto Industries Inc.

32. Global Contraceptives Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Contraceptives Market

34. Recent Developments In The Contraceptives Market

35. Contraceptives Market High Potential Countries, Segments and Strategies

35.1 Contraceptives Market In 2029 - Countries Offering Most New Opportunities
35.2 Contraceptives Market In 2029 - Segments Offering Most New Opportunities
35.3 Contraceptives Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer